The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience

Patients’ responses to breast cancer neoadjuvant chemotherapy (NACT) differ because of heterogeneous tumor characteristics. Reports about NACT progression are sporadic. Here we enrolled 1187 patients who received NACT in our cancer center between January 1, 2007, and December 31, 2016. We analyzed t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Biol Ther
Autors principals: Zheng, Yurong, Ding, Xiaowen, Zou, Dehong, Zhang, Fanrong, Qin, Chengdong, Yang, Hongjian, Mo, Wenju, Ding, Yuqin, Yu, Yang
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515534/
https://ncbi.nlm.nih.gov/pubmed/32420815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1756707
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars